Clinical Trials Directory

Trials / Completed

CompletedNCT04059380

Evaluation of iMmune Function in Post-surgical and AuToimmune HYpoparathyroidism (EMPATHY)

Evaluation of iMmune Function in Post-surgical and AuToimmune HYpoparathyroidism: The EMPATHY Study

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University of Roma La Sapienza · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is an observational pilot study for the evaluation of immune function, infectious diseases, psychometric status and quality of life in patients with hypoparathyroidism compared to healthy controls.

Detailed description

This is an observational pilot study for the evaluation of immune function, infectious diseases, psychometric status and quality of life in patients with hypoparathyroidism compared to healthy controls. All patients with Hypoparathyroidism will be on established conventional therapy with calcium supplements and calcitriol. According to guidelines, possible confounding factors (i.e. Vitamin D, serum magnesium levels) will be evaluated at screening visit. Age-, sex- and BMI- matched healthy controls will be enrolled. Patients and controls will undergo a screening visit (V0) and a baseline visit (V1) in the following month. The primary outcome will be the immune profiling of patients with hypoparathyroidism compared to healthy controls by the quantification of peripheral blood mononuclear cells (PBMC) subpopulations assessed by flow cytometry. Secondary Outcome Measures will be: Functional evaluation of PBMC cytokine secretion assessed by flow cytometry Evaluation of calcium signaling components expression compared to healthy controls Evaluation of PTHR1 expression in immune cells compared to healthy controls Evaluation of inflammatory cytokines production compared to healthy controls. Evaluation of quality of life compared to healthy controls. Quality of life will be measured by Short Form (SF)-36-Item Health Survey total score, SF-36-Item Health Survey physical component summary score and SF-36-Item Health Survey mental component summary score. Evaluation of infectious diseases frequencies and severity compared to healthy controls. Infectious diseases will be evaluated by an adaptation of Infectious Diseases Questionnaire (GNC). Psychometric evaluation by self-administered questionnaires: Beck depression Index, Middlesex Hospital Questionnaire. Sleep disturbances evaluation by The Pittsburgh Sleep Quality Index (PSQI) self reported questionnaire.

Conditions

Timeline

Start date
2019-05-13
Primary completion
2020-10-31
Completion
2020-10-31
First posted
2019-08-16
Last updated
2022-12-06

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04059380. Inclusion in this directory is not an endorsement.